Conference
Validation of the association of RECIST 1.0 changes with survival in men with metastatic castration-resistant prostate cancer (mCRPC) treated on SWOG Study S0421.
Authors
Pond GR; Sonpavde G; Plets M; Tangen CM; Hussain M; Lara P; Goldkorn A; Garzotto M; Mack PC; Higano CS
Volume
34
Pagination
pp. 5079-5079
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2016
DOI
10.1200/jco.2016.34.15_suppl.5079
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X